Cardiol Therapeutics Inc. CRDL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.23% | -36.57% | 11.45% | 22.48% | -25.36% |
| Total Depreciation and Amortization | -54.89% | 12.07% | -46.24% | -87.38% | -59.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.59% | 161.84% | 68.34% | -51.55% | 216.37% |
| Change in Net Operating Assets | 15.68% | 182.04% | -163.94% | 76.95% | -15.10% |
| Cash from Operations | 3.80% | -9.94% | 6.20% | 11.73% | 5.76% |
| Capital Expenditure | 53.19% | -318.07% | 50.00% | 62.07% | -67.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 53.19% | -318.07% | 50.00% | 62.07% | -67.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | -200.00% | -50.00% |
| Issuance of Common Stock | 7,161.81% | -- | -24.90% | -- | -60.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 82.01% | -- | -- |
| Cash from Financing | 11,991.89% | 103,369.79% | -16.48% | -197.06% | -74.08% |
| Foreign Exchange rate Adjustments | 155.78% | 315.45% | -132.83% | 203.12% | -470.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.78% | 189.82% | -33.08% | 20.00% | -10.76% |